AK
Anand Kumar Parmanandka
About Anand Kumar Parmanandka
Data last updated:
Anand Kumar Parmanandka has 8 years in corporate governance. Holds Additional Director and Director roles. Currently with 7 companies, including Alventa Pharma Limited and Aleris Pharmaceuticals Limited. Formerly with 2 companies, such as Concept Biosciences India Private Limited and Gayatri Ensemble Private Limited. Engaged in General Business. Contributes to corporate operations. The 5 current companies with reported revenue have a combined latest revenue of ₹426 Cr; the largest is Allenburys Pharma Limited at ₹159 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Allenburys Pharma Limited U93020WB2020PLC240519 | Director | 15 Oct 2020 | 2020 | ₹159 Cr (FY 2025) | Active |
 Alventa Pharma Limited U24299WB2016PLC225674 | Additional Director | 29 Apr 2018 | 2016 | ₹143 Cr (FY 2025) | Active |
| Aleris Pharmaceuticals Limited U24304WB2021PLC245141 | Director | 13 May 2021 | 2021 | ₹75.07 Cr (FY 2025) | Active |
| Elder Laboratories Limited U24309WB2021PLC245140 | Director | 13 May 2021 | 2021 | ₹49.51 Cr (FY 2024) | Active |
| Nicholas Pharma India Limited U85100WB2021PLC244244 | Director | 30 Mar 2021 | 2021 | ₹40,000 (FY 2023) | Active |
| Sheom Enclave Llp ACI-3944 | Designated Partner | 29 Jul 2025 | 2024 | – | Active |
| Alventa Realty Llp ACP-6058 | Designated Partner | 02 Jul 2025 | 2025 | – | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Concept Biosciences India Private Limited U85190WB2008PTC127172 | Director | 26 Jul 2019 | 2008 | ₹114 Cr (FY 2019) | Under Liquidation |
| Gayatri Ensemble Private Limited U17120WB2008PTC130826 | Director | 31 Oct 2019 | 2008 | ₹5 Lakh (FY 2022) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anand Kumar Parmanandka
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anand Kumar Parmanandka
Anand Kumar Parmanandka has 8 years in corporate governance. Holds Additional Director and Director roles. Currently with 7 companies, including Alventa Pharma Limited and Aleris Pharmaceuticals Limited. Formerly with 2 companies, such as Concept Biosciences India Private Limited and Gayatri Ensemble Private Limited. Engaged in General Business. Contributes to corporate operations. The 5 current companies with reported revenue have a combined latest revenue of ₹426 Cr; the largest is Allenburys Pharma Limited at ₹159 Cr (FY 2025).
Anand Kumar Parmanandka is associated with 7 companies as Additional Director and Director, including Allenburys Pharma Limited (₹159 Cr), Alventa Pharma Limited (₹143 Cr), Aleris Pharmaceuticals Limited (₹75.07 Cr).
Anand Kumar Parmanandka has expertise in General Business.
Anand Kumar Parmanandka has 8 years in corporate governance.
By reported revenue, the largest current company of Anand Kumar Parmanandka is Allenburys Pharma Limited, with revenue of ₹159 Cr (FY 2025).
The 5 current companies of Anand Kumar Parmanandka that report revenue have a combined latest revenue of ₹426 Cr.
Anand Kumar Parmanandka currently holds positions at 7 companies; the 5 largest by reported revenue are Allenburys Pharma Limited (₹159 Cr), Alventa Pharma Limited (₹143 Cr), Aleris Pharmaceuticals Limited (₹75.07 Cr), Elder Laboratories Limited (₹49.51 Cr), Nicholas Pharma India Limited (₹40,000).